#lung-cancer

Prospective data show proton beam therapy improves survival while sparing healthy tissue and preserving quality of life in lung cancer patients.

Researchers identify miR-149-5p as a key driver of immune escape in bronchial lesions that can progress to squamous cell lung cancer.

New clinical data shows proton beam therapy delivers strong survival rates for advanced lung cancer while reducing damage to healthy tissue.

Scientists discover how premalignant lung cells suppress immune surveillance, revealing potential targets for intercepting cancer before it fully develops.